新加坡患者可能通过研发合作伙伴关系获得更多新型抗癌药物。
新加坡患者可能通过研发合作伙伴关系获得更多新型抗癌药物。 Singapore patients may get greater access to novel cancer drugs under R&D partnership 作者: Zhaki Abdullah The Singapore Translational Cancer Consortium is the 27th member of the cancer immunotherapy research network. Read more at straitstimes.com. 新加坡转化癌症联盟是癌症免疫疗法研究网络的第27个成员。更多内容请访问straitstimes.com。 SINGAPORE A national cancer consortium here has been admitted into an international expert network that will allow it … Read more